Florida Clears Genetic Technologies' BrevaGen for Sale | GenomeWeb

NEW YORK (GenomeWeb News) – Genetic Technologies today said that its BrevaGen breast cancer risk stratification test has been cleared by Florida for sale in the state.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: comprehensive analysis of somatic mutations in breast cancer, and more.

A number of studies indicate that genes might influence political beliefs, Scientific American Mind reports.

Craig Venter's Human Longevity is deeply phenotyping individuals and capturing their genetic profiles to explore aging.

The San Francisco Business Times examines Verily's latest hires.